
Quezada Lab
@QuezadaLab
Followers
1K
Following
189
Media
29
Statuses
321
Immune Regulation and Tumour Immunotherapy Group led by @squezadd, based at the Cancer Institute of University College of London, UCL.
London, England
Joined September 2018
RT @ACIR_org: Depletion of Tregs with a non-IL-2-blocking anti-CD25 enhanced antitumor responses in brain tumors and synergized with anti-….
0
2
0
RT @jsoriamd: CHIP is a common, age-related condition where mutated blood stem cells expand without causing blood disorders. CHIP raises th….
0
44
0
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies: Amazing collaboration led by @CR_UK funded @QuezadaLab @galvez_cancino @uclcancer and colleagues!.
6
16
60
RT @EJohnWherry: This is exactly right. Gutting the NIH will lead to a rapid labor shortage and all these jobs going overseas.
0
20
0
RT @CharlesSwanton: Many congratulations @FAndreMD @cncurtis on the Susan G Komen awards - a great recognition for all your discoveries….
0
1
0
RT @CRUKCOLcentre: Happy Post Doc Appreciation Week! Our facilities are used by Post Docs at @uclcancer, @kingsmedicine, @QMBCI and @TheCri….
0
1
0
Looking fwd to a great conference!!!.
Good and Bad CD4 T-cell Help:.Cornelis JM Melief, Sergio Quezada, and Robert D. Schreiber will address this topic in a plenary session at the AACR Special Conference on Tumor Immunology and Immunotherapy (October 18-21, Boston). #AACRtii24 @squezadd
0
2
9
Tremendous line up of speakers! Come join us in Boston!.
Submit an abstract by August 5 for the AACR Special Conference on Tumor Immunology and Immunotherapy (October 18-21, Boston), chaired by Yvonne Y. Chen, Sergio Quezada, Robert D. Schreiber, and Fernando Vidal-Vanaclocha. Learn more:.#AACRtii24 @squezadd
0
2
6
Great collaboration with @Marcrmansour @samuels_yardena @SwantonLab @SineRekerHAdrup @uclcancer and @achillestx funded by @EUhorizon2020.
Really happy to share a link to our most recent preprint: In it we describe the development of a state-of-the-art immunogenicity predictor, laying the necessary foundation for the @AgDecod DECOD-Ag program.
0
2
13
Really happy to share a link to our most recent preprint: In it we describe the development of a state-of-the-art immunogenicity predictor, laying the necessary foundation for the @AgDecod DECOD-Ag program.
0
3
28
RT @NatureRevCancer: Don´t miss this Review summarizing the different antibody-based approaches for targeting cancer cells including #Check….
0
144
0
RT @CRUKCOLcentre: Today is #InternationalWomensDay. We are proud to support the many women scientists, students and technical staff at the….
0
8
0
RT @sitcancer: We can't wait to see you Dr. Delgoffe! Thanks for your leadership in bringing this awesome event to fruition! See everyone S….
0
1
0
RT @evan_foundation: While in London, Gavin had the privilege of rounding our “Treats & Treasures Trolley” on the onc floor at @GreatOrmond….
0
1
0
RT @CRUKCOLcentre: Proud to announce Team MATCHMAKERS has been one of the 5 successful @CancerGrand. @squezadd @uclcancer is part of the Te….
0
2
0
We are so proud and honoured to be part of the incredible #MATCHMAKERS team with the challenge to decipher the T-cell receptor cancer-recognition code. This grand challenge has huge potential to impact the future development of novel therapeutics for cancer! .1/2-.
📢 Announcing five new global #CancerGrandChallenges teams! 📢. We're thrilled to announce five new teams, each receiving up to $25m over five years to tackle some of cancer's toughest challenges. Meet the teams: @CR_UK @theNCI
4
4
56
Very exciting to have our lab members, Despoina Karagianni @despoinakg and Felipe Galvez-Cancino @galvez_cancino, be shortlisted in the Further, Faster, Together (Industry-Academia Collaboration) category in the #IEAwards2024 along with our amazing collaborators at @CR_Horizons.
🏆 Hot off the press: the shortlist for our Innovation & Entrepreneurship Awards 2024!. Congratulations to everyone – we’re looking forward to celebrating your achievements at the Ceremony on 20 March. #IEAwards2024.@oxengsci, @pentabind, @uclcancer, @EdinCRC, @UniofNewcastle,
0
1
12